133 related articles for article (PubMed ID: 32327350)
1. Synthesis and cytotoxic effects of 2-thio-3,4-dihydroquinazoline derivatives as novel T-type calcium channel blockers.
Nam Y; Ryu KD; Jang C; Moon YH; Kim M; Ko D; Chung KS; Gandini MA; Lee KT; Zamponi GW; Lee JY
Bioorg Med Chem; 2020 Jun; 28(11):115491. PubMed ID: 32327350
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and SAR study of T-type calcium channel blockers. Part II.
Choe YJ; Seo HN; Jung SY; Rhim H; Kim J; Choo DJ; Lee JY
Arch Pharm (Weinheim); 2008 Oct; 341(10):661-4. PubMed ID: 18816587
[TBL] [Abstract][Full Text] [Related]
3. In vitro cytotoxicity on human ovarian cancer cells by T-type calcium channel blockers.
Jang SJ; Choi HW; Choi DL; Cho S; Rim HK; Choi HE; Kim KS; Huang M; Rhim H; Lee KT; Lee JY
Bioorg Med Chem Lett; 2013 Dec; 23(24):6656-62. PubMed ID: 24220170
[TBL] [Abstract][Full Text] [Related]
4. Structural optimization, synthesis and in vitro synergistic anticancer activities of combinations of new N3-substituted dihydropyrimidine calcium channel blockers with cisplatin and etoposide.
El-Wakil MH; Teleb M; Abu-Serie MM; Huang S; Zamponi GW; Fahmy H
Bioorg Chem; 2021 Oct; 115():105262. PubMed ID: 34411980
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and SAR studies of a novel series of T-type calcium channel blockers.
Park SJ; Park SJ; Lee MJ; Rhim H; Kim Y; Lee JH; Chung BY; Lee JY
Bioorg Med Chem; 2006 May; 14(10):3502-11. PubMed ID: 16434203
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of fluoro-substituted 3,4-dihydroquinazoline derivatives for cytotoxic and analgesic effects.
Kim JH; Jeong HR; Jung DW; Yoon HB; Kim SY; Kim HJ; Lee KT; Gadotti VM; Huang J; Zhang FX; Zamponi GW; Lee JY
Bioorg Med Chem; 2017 Sep; 25(17):4656-4664. PubMed ID: 28720332
[TBL] [Abstract][Full Text] [Related]
7. 3,4-Dihydroquinazoline derivatives as novel selective T-type Ca2+ channel blockers.
Lee YS; Lee BH; Park SJ; Kang SB; Rhim H; Park JY; Lee JH; Jeong SW; Lee JY
Bioorg Med Chem Lett; 2004 Jul; 14(13):3379-84. PubMed ID: 15177437
[TBL] [Abstract][Full Text] [Related]
8. Discovery of potent T-type calcium channel blocker.
Seo HN; Choi JY; Choe YJ; Kim Y; Rhim H; Lee SH; Kim J; Joo DJ; Lee JY
Bioorg Med Chem Lett; 2007 Nov; 17(21):5740-3. PubMed ID: 17869104
[TBL] [Abstract][Full Text] [Related]
9. T-type Ca2+ channel blockers suppress the growth of human cancer cells.
Heo JH; Seo HN; Choe YJ; Kim S; Oh CR; Kim YD; Rhim H; Choo DJ; Kim J; Lee JY
Bioorg Med Chem Lett; 2008 Jul; 18(14):3899-901. PubMed ID: 18585035
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological activity of 3,4-dihydroquinazolines for selective T-type Ca2+ channel blockers.
Rhim H; Lee YS; Park SJ; Chung BY; Lee JY
Bioorg Med Chem Lett; 2005 Jan; 15(2):283-6. PubMed ID: 15603940
[TBL] [Abstract][Full Text] [Related]
11. Novel T-type calcium channel blockers: dioxoquinazoline carboxamide derivatives.
Jo MN; Seo HJ; Kim Y; Seo SH; Rhim H; Cho YS; Cha JH; Koh HY; Choo H; Pae AN
Bioorg Med Chem; 2007 Jan; 15(1):365-73. PubMed ID: 17035033
[TBL] [Abstract][Full Text] [Related]
12. In vitro synergistic anticancer activity of the combination of T-type calcium channel blocker and chemotherapeutic agent in A549 cells.
Byun JS; Sohn JM; Leem DG; Park B; Nam JH; Shin DH; Shin JS; Kim HJ; Lee KT; Lee JY
Bioorg Med Chem Lett; 2016 Feb; 26(3):1073-1079. PubMed ID: 26739776
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of novel T-type calcium channel blockers.
Choi JY; Seo HN; Lee MJ; Park SJ; Park SJ; Jeon JY; Kang JH; Pae AN; Rhim H; Lee JY
Bioorg Med Chem Lett; 2007 Jan; 17(2):471-5. PubMed ID: 17064894
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cellular proliferation and induction of apoptosis in human lung adenocarcinoma A549 cells by T-type calcium channel antagonist.
Choi DL; Jang SJ; Cho S; Choi HE; Rim HK; Lee KT; Lee JY
Bioorg Med Chem Lett; 2014 Mar; 24(6):1565-70. PubMed ID: 24529871
[TBL] [Abstract][Full Text] [Related]
15. 3D QSAR studies on 3,4-dihydroquinazolines as T-type calcium channel blocker by comparative molecular similarity indices analysis (CoMSIA).
Jeong JA; Cho H; Jung SY; Kang HB; Park JY; Kim J; Choo DJ; Lee JY
Bioorg Med Chem Lett; 2010 Jan; 20(1):38-41. PubMed ID: 19951839
[TBL] [Abstract][Full Text] [Related]
16. Growth inhibition of human cancer cells in vitro by T-type calcium channel blockers.
Lee JY; Park SJ; Park SJ; Lee MJ; Rhim H; Seo SH; Kim KS
Bioorg Med Chem Lett; 2006 Oct; 16(19):5014-7. PubMed ID: 16876410
[TBL] [Abstract][Full Text] [Related]
17. In vivo evaluation of oral anti-tumoral effect of 3,4-dihydroquinazoline derivative on solid tumor.
Kang HB; Rim HK; Park JY; Choi HW; Choi DL; Seo JH; Chung KS; Huh G; Kim J; Choo DJ; Lee KT; Lee JY
Bioorg Med Chem Lett; 2012 Jan; 22(2):1198-201. PubMed ID: 22177784
[TBL] [Abstract][Full Text] [Related]
18. Novel quinazoline derivatives bearing various 6-benzamide moieties as highly selective and potent EGFR inhibitors.
Hou W; Ren Y; Zhang Z; Sun H; Ma Y; Yan B
Bioorg Med Chem; 2018 May; 26(8):1740-1750. PubMed ID: 29523467
[TBL] [Abstract][Full Text] [Related]
19. New derivatives of quinazoline and 1, 2-dihydroquinazoline n3-oxide with expected antitumor activity.
Mikiciuk-Olasik E; Baszczak-Swiatkiewiz K; Zurek E; Krajewska U; Rózalski M; Kruszyński R; Bartczak TJ
Arch Pharm (Weinheim); 2004 May; 337(5):239-46. PubMed ID: 15095417
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of novel T-type Ca2+ channel blockers.
Jung HK; Doddareddy MR; Cha JH; Rhim H; Cho YS; Koh HY; Jung BY; Pae AN
Bioorg Med Chem; 2004 Aug; 12(15):3965-70. PubMed ID: 15246072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
